|
|
|
|
|
|
|
|
|
|
ScienceDaily
Disabling critical 'node' revs up attack when cancer immunotherapies fall short
Preclinical study shows blocking tumor interferon pathway antagonizes resistance
- Date: December 1, 2016
Monday, December 05, 2016
(PD1 and CTLA-4) Disabling critical 'node' revs up attack when cancer immunotherapies fall short
ScienceDaily
Disabling critical 'node' revs up attack when cancer immunotherapies fall short
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.